First Wave Biopharma Inc Stock Ownership - Who owns First Wave Biopharma?

Insider buying vs selling

Have First Wave Biopharma Inc insiders been buying or selling?
Charles J. CasamentoDirector2023-09-1510$0.43
Charles J. CasamentoDirector2023-08-316,053$0.30
Sarah RomanoChief Financial Officer2023-07-031,977$1.54
James SapirsteinPresident and CEO2023-07-033,349$1.54
Sarah RomanoChief Financial Officer2023-04-031,975$2.50
James SapirsteinPresident and CEO2023-04-033,347$2.50

1 of 1

FWBI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FWBI insiders and whales buy or sell their stock.

FWBI Shareholders

What type of owners hold First Wave Biopharma Inc stock?
Edmund Burke Ross Jr.42.51%3,040,555$881.76kInsider
Pelican Partners LLC22.76%1,627,796$472.06kInsider
Johan M. Spoor5.85%418,319$121.31kInsider
Charles J. Casamento1.72%123,096$35.70kInsider
Edward Borkowski1.40%99,836$28.95kInsider
David Andrew Hoffman1.27%90,778$26.33kInsider
Vern Lee Schramm1.27%90,498$26.24kInsider
Alastair Riddell1.19%85,185$24.70kInsider
Mary Theresa Coelho1.18%84,745$24.58kInsider
Maged Shenouda0.87%62,500$18.13kInsider

1 of 3

FWBI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FWBI0.66%81.00%Net SellingNet Selling
ADTX12.28%87.72%Net SellingNet Selling

First Wave Biopharma Stock Ownership FAQ

Who owns First Wave Biopharma?

First Wave Biopharma (NASDAQ: FWBI) is owned by 0.66% institutional shareholders, 81.00% First Wave Biopharma insiders, and 18.34% retail investors. Edmund Burke Ross Jr. is the largest individual First Wave Biopharma shareholder, owning 3.04M shares representing 42.51% of the company. Edmund Burke Ross Jr.'s First Wave Biopharma shares are currently valued at $900.00k.

If you're new to stock investing, here's how to buy First Wave Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.